EPISODE · Apr 19, 2022 · 12 MIN
BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB:BICX)(“the Company”), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Director, CEO, and CFO of the Company, Lourdes Felix, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB:BICX)(“the Company”), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Director, CEO, and CFO of the Company, Lourdes Felix, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m